AANA Journal: Dexmedetomidine versus Opioids on Labor Analgesia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Image For Activity Cover
Availability
On-Demand
Expires on 07/08/2027
Cost
Member: $50.00
Non-Member: $75.00
Credit Offered
1.25 Class A Credits
1.25 Pharmacology Credits
This course satisfies the CPCA remediation requirement for Applied Clinical Pharmacology.

If you did not meet the CPCA standard, you will need 1-4 Class A credits above and beyond the standard 60 Class A credits required for renewal of your CRNA credential. Visit your NBCRNA portal to review exam results for more information. 


This course evaluates the effectiveness of neuraxial dexmedetomidine versus opioids for labor pain relief, highlighting dexmedetomidine's advantages in extending analgesia duration, lowering pain scores, and hastening onset compared to opioids. Explore the benefits and considerations of using dexmedetomidine over opioids in labor analgesia.


Learning Outcomes:
  1. Understand the efficacy and safety of neuraxial dexmedetomidine versus neuraxial opioids.
  2. Compare dexmedetomidine and opioids as it relates to prolonged analgesia, reducing pain scores, and offering a safer alternative for labor pain managment.

This program has been prior approved by the American Association of Nurse Anesthesiology for 1.25 Class A CE credits; Code Number 1044691; Expiration Date 6/10/2027.

AANA designates this program as meeting the criteria for up to 1.25 CE Credits in pharmacology/therapeutics.

  • Eduardo Cedeno, DNAP, CRNA (article)
  • Mary Ann Janice L. Vo, DNAP, CRNA, FNP-C (article)
  • Tito D. Tubog, PhD, DNAP, CRNA (article)
  • Scott McGowan, DNP, CRNA

Accreditation Information:
The American Association of Nurse Anesthesiology is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. 

AANA is an approved provider by the California Board of Registered Nursing, CEP #10862.

Disclosure Statement:
Any relevant relationship between an ineligible company and an individual with the ability to influence clinical content will be identified by the Nurse Planner within the activity. Any relevant relationship between an ineligible company and an individual with the ability to influence clinical content has been mitigated.

Post-Test Attempt Notice:

A minimum passing score of 80% is required to pass this course. You have TWO opportunities to achieve a passing score. If you fail to achieve a passing score of 80%, you will not receive CE credit for this course.

Content Disclaimer:
The views, information, or opinions expressed within the videos and audio are solely those of the individuals involved and do not necessarily represent those of the American Association of Nurse Anesthesiology.

Course content has been prepared by the presenter/developer, and each viewer agrees that the presenter/developer is solely responsible for the content and the accuracy thereof. The viewer agrees that the American Association of Nurse Anesthesiology has no responsibility or liability for the accuracy or completeness of the content.

Refund Policy:
Continuing education activities are nonrefundable.

 
AANA white logo
10275 W. Higgins Rd., Suite 500, Rosemont, IL 60018
Phone: 847-692-7050
 
AANA® is a registered trademark of the American Association of Nurse Anesthesiology. Privacy policy. Copyright © 2024 American Association of Nurse Anesthesiology. All rights reserved.
Android App Download IOS App Download Powered By